• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BECTON DICKINSON INFUSION THERAPY SYSTEMS INC. BD INSYTE-N¿ AUTOGUARD¿ SHIELDED IV CATHETER; INTRAVASCULAR CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BECTON DICKINSON INFUSION THERAPY SYSTEMS INC. BD INSYTE-N¿ AUTOGUARD¿ SHIELDED IV CATHETER; INTRAVASCULAR CATHETER Back to Search Results
Catalog Number 381511
Device Problems Material Deformation (2976); Suction Failure (4039)
Patient Problem Extravasation (1842)
Event Date 03/28/2019
Event Type  malfunction  
Manufacturer Narrative
A device evaluation is anticipated, but has not yet begun.Upon completion of the investigation, a supplemental report will be filed.
 
Event Description
It was reported that there was a difficult penetration due to poor catheter tip, as well as flashback with a bd insyte-n¿ autoguard¿ shielded iv catheter.The following information was provided by the initial reporter: it was reported that the bevel area of the catheter tip is bubbled.It was also reported that there is difficulty penetrating the skin, no or very little flashback, and veins are blowing.Uvc had to be placed which is more invasive and increased risk for infection.
 
Event Description
It was reported that there was a difficult penetration due to poor catheter tip, as well as flashback with a bd insyte-n¿ autoguard¿ shielded iv catheter.The following information was provided by the initial reporter: it was reported that the bevel area of the catheter tip is bubbled.It was also reported that there is difficulty penetrating the skin, no or very little flashback, and veins are blowing.Uvc had to be placed which is more invasive and increased risk for infection.
 
Manufacturer Narrative
H.6.Investigation: review of dhr revealed all required challenge samples, set-up and in process testing was performed in accordance with the quality plans.Review disclosed no reject activity findings throughout the build of this lot that would impact the outcome of the quality of the product relevant to the defect.Without the actual sample for evaluation and testing there was no physical evidence to confirm or support manufacturing process related issues for the reported defect.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BD INSYTE-N¿ AUTOGUARD¿ SHIELDED IV CATHETER
Type of Device
INTRAVASCULAR CATHETER
Manufacturer (Section D)
BECTON DICKINSON INFUSION THERAPY SYSTEMS INC.
9450 south state street
sandy UT 84070
MDR Report Key8569029
MDR Text Key143694248
Report Number1710034-2019-00476
Device Sequence Number1
Product Code FOZ
UDI-Device Identifier30382903815112
UDI-Public30382903815112
Combination Product (y/n)N
PMA/PMN Number
K952861
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional,other,use
Type of Report Initial,Followup
Report Date 05/24/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received05/01/2019
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Other
Device Expiration Date09/30/2021
Device Catalogue Number381511
Device Lot Number8275532
Date Manufacturer Received04/15/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Other;
-
-